%PDF-1.6
%
1 0 obj
<>stream
2022-05-31T14:00:02+05:30
2022-06-13T01:49:06-07:00
2022-06-13T01:49:06-07:00
LaTeX with hyperref package
Acrobat Distiller 10.0.0 (Windows); modified using iText 4.2.0 by 1T3XT
10.1002/cac2.12313
10.1002/(ISSN)2523-3548
3
VoR
10.1002/cac2.12313
application/pdf
Epi‐immunotherapy for cancers: rationales of epi‐drugs in combination with immunotherapy and advances in clinical trials
uuid:192d2da4-027f-3666-8e52-19d2d5f53a42
uuid:3033b05c-ab37-4024-8141-c1e356609cdc
endstream
endobj
4 0 obj
<>stream
x[YwF~ׯ#xV 8lk:Ӷrҙv MVܿ~V H>B-݅ξ{AO.?IٝIW6g?ޜ%wDMn|&$y.v**5IbLng8Qje$y%,]b'WO3*s'8r!\ q$@h cNsK^hcWY|ể>>p@7) wq:3,74\8Yb`
z'/[x9uf{>C85LsM8J9,NsZ{>pnI$1Pd}@Rp@;~fᨢ6f۸lUcVv {p-7?B*^E}[7i`s|q&U,ff1M,62Ms&H
I|SeCdQO/@RϚˢ7m7łQKxx:2>?W ×lӞ0BL d O)P`P@/.M!2D]Nx85XvIf|`D%:8foSVQ=Ey{!19Sg[?Gt3S].{myETDu/3~guL/.g4>%):V3:UWQ(1^W.&^EXp2|6M
wY.Q lG}9 {;| 4[#o,]bjESTKu){\+e7י~mT\8xTmGGjxDG^,mł4CK9m.j'Ҩ&{ܵkXu<2=Uq
(ft#Luh ylѷnQ`La{/)EujjrNQĈg-g@'I&",=&